Valeritas Holdings, Inc. announced the election of Katherine D. Crothall, PhD, to the company’s Board of Directors, effective October 10, 2016. Dr. Crothall will serve as an independent director, bringing the total number of independent directors to four. In conjunction with the appointment of Dr. Crothall, Cameron Hui, who represents CRG, will step down from the Board of Directors as of October 10, 2016 resulting in a Board with a majority of independent directors. Dr. Crothall currently serves as President, CEO, and Chairman of the Board of Aspire Bariatrics. Prior to Aspire, Dr. Crothall was a Principal at Liberty Venture Partners.